Calidi Biotherapeutics, Inc. 10-Q filing
Filed 2026-05-14 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001493152-26-023140
- Form type
- 10-Q
- CIK
- 0001855485
- Primary document
- https://www.sec.gov/Archives/edgar/data/1855485/000149315226023140/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Calidi Biotherapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-4.2M | - | - |
| Net Income | $-4.1M | - | - |
| Eps Basic | -0.43 | - | - |
| Eps Diluted | -0.43 | - | - |
| Total Assets | $9.6M | - | - |
| Total Liabilities | $4.7M | - | - |
| Shareholders Equity | $4.9M | - | - |
| Operating Cash Flow | $-4.1M | - | - |